Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,202 Cr
up ₹4.5 Cr vs Feb 2023
- Stocks held
- 23
- down 1 vs Feb 2023
- Top 10 weight
- 69.0%
- of the portfolio in its ten largest
- Cash & debt
- <0.1%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2023 it disclosed 23 stocks worth ₹1,202 Cr, up ₹4.5 Cr from Feb 2023. Its largest positions were Sun Pharmaceutical Industries Limited (17.3%), Cipla Limited (10.0%), Apollo Hospitals Enterprise Limited (6.7%); the ten largest together made up 69.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 69.9% of its equity. Cash and debt stood at <0.1%. Compared with Feb 2023 the fund entered 0 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
1%
Holds more cash than 1% of peers
What these mean: concentration · cash
Holdings in March 2023
Download CSVEvery line the fund disclosed, with the change against Feb 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 17.28% | up 0.40 pts | ₹208 Cr | up ₹5.6 Cr | Added |
| Cipla Limited | 9.98% | up 1.16 pts | ₹120 Cr | up ₹14.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 6.68% | down 0.17 pts | ₹80.3 Cr | down ₹1.7 Cr | Trimmed |
| Procter & Gamble Health Limited | 6.19% | down 0.01 pts | ₹74.4 Cr | up ₹14 L | Held |
| Lupin Limited | 5.50% | down 0.11 pts | ₹66.1 Cr | down ₹1.1 Cr | Trimmed |
| IPCA Laboratories Limited | 5.32% | down <0.01 pts | ₹64 Cr | up ₹19 L | Held |
| Alkem Laboratories Limited | 5.03% | up 0.31 pts | ₹60.4 Cr | up ₹3.9 Cr | Added |
| Alembic Pharmaceuticals Limited | 4.53% | up 0.32 pts | ₹54.4 Cr | up ₹4 Cr | Added |
| Dr. Reddy's Laboratories Limited | 4.31% | up 0.27 pts | ₹51.8 Cr | up ₹3.4 Cr | Added |
| Zydus Lifesciences Limited | 4.23% | up 0.21 pts | ₹50.8 Cr | up ₹2.7 Cr | Added |
| Suven Pharmaceuticals Limited | 3.85% | down 0.08 pts | ₹46.3 Cr | down ₹74 L | Trimmed |
| Indoco Remedies Limited | 3.42% | down 0.25 pts | ₹41.1 Cr | down ₹2.8 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.32% | up 0.10 pts | ₹39.9 Cr | up ₹1.4 Cr | Added |
| Intuitive Surgical Inc | 3.27% | up 0.29 pts | ₹39.3 Cr | up ₹3.7 Cr | Added |
| Globus Medical Inc | 2.58% | down 0.15 pts | ₹31 Cr | down ₹1.7 Cr | Trimmed |
| Abbott Laboratories | 2.18% | down 0.02 pts | ₹26.1 Cr | down ₹9 L | Held |
| ICICI Lombard General Insurance Company Limited | 2.15% | down 0.07 pts | ₹25.8 Cr | down ₹78 L | Trimmed |
| Aarti Drugs Limited | 2.09% | down 0.18 pts | ₹25.1 Cr | down ₹2.1 Cr | Trimmed |
| Syngene International Limited | 1.86% | up 0.04 pts | ₹22.3 Cr | up ₹52 L | Added |
| Kovai Medical Center and Hospital Limited | 1.77% | down 0.08 pts | ₹21.3 Cr | down ₹91 L | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.66% | down 0.07 pts | ₹20 Cr | down ₹79 L | Trimmed |
| Illumina Inc | 1.31% | up 0.16 pts | ₹15.7 Cr | up ₹2 Cr | Added |
| MedPlus Health Services Limited | 1.04% | down 0.03 pts | ₹12.5 Cr | down ₹31 L | Trimmed |
| Pfizer Limited | 0.44% | down 0.04 pts | ₹5.3 Cr | down ₹50 L | Trimmed |
| Cash, TREPS & receivables | 0.05% | down 0.48 pts | ₹56 L | down ₹5.8 Cr | Trimmed |
What changed, Feb 2023 to Mar 2023
New New positions (0)
None.
Exited Exited (1)
- Max Healthcare Institute Limitedwas 1.5% · ₹18.2 Cr
Added Biggest additions
- Cipla Limitedup ₹14.4 Cr (+1.16% pts)
- Sun Pharmaceutical Industries Limitedup ₹5.6 Cr (+0.40% pts)
- Alembic Pharmaceuticals Limitedup ₹4 Cr (+0.32% pts)
- Alkem Laboratories Limitedup ₹3.9 Cr (+0.31% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2023, the weight rose most in Pharmaceuticals & Biotechnology (+1.9 pts) and Healthcare Equipment & Supplies (+0.1 pts), and fell most in Healthcare Services (−1.6 pts) and Pharmaceuticals (−0.3 pts).
- Pharmaceuticals & Biotechnology68.0% → 69.9%+1.9 pts
- Healthcare Equipment & Supplies5.8% → 6.0%+0.1 pts
- Healthcare Services16.8% → 15.2%−1.6 pts
- Pharmaceuticals6.0% → 5.7%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2020 | Mar 2022 | Sep 2022 | Dec 2022 | Feb 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 67.4% | 54.7% | 59.2% | 63.9% | 68.0% | 69.9% |
| Healthcare Services | 19.0% | 27.8% | 25.1% | 18.9% | 16.8% | 15.2% |
| Healthcare Equipment & Supplies | — | 6.4% | 5.6% | 7.1% | 5.8% | 6.0% |
| Pharmaceuticals | 11.6% | 7.0% | 6.7% | 6.4% | 6.0% | 5.7% |
| Insurance | 2.1% | 2.5% | 2.4% | 2.6% | 2.3% | 2.2% |
| Retailing | — | 1.5% | 1.0% | 1.0% | 1.1% | 1.1% |
Allocation in Mar 2023change vs Feb 2023
- Pharmaceuticals & Biotechnology (12)69.9%▲ 1.9 pts
- Healthcare Services (5)15.2%▼ 1.6 pts
- Healthcare Equipment & Supplies (2)6.0%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Mar 2023
<0.1%
▼ 0.5 pts vs Feb 2023
- Cash alone
- <0.1%
- cash and net receivables
- A year earlier
- −<0.1%
- Mar 2022 · now ▲ 0.1 pts
- Last 12 months
- −<0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.